STME Stock Chart & Stats
$0.30
-$0.03(-6.00%)
At close: 4:00 PM EST
$0.30
-$0.03(-6.00%)
Day’s Range― - ―
52-Week Range$0.25 - $0.48
Previous CloseN/A
Volume500.00
Average Volume (3M)153.00
Market Cap
$5.83M
Enterprise Value$8.13M
Total Cash (Recent Filing)$10.26K
Total Debt (Recent Filing)$779.99K
Price to Earnings (P/E)―
Beta-4.20
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding21,141,272
10 Day Avg. Volume169
30 Day Avg. Volume153
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)-7.64
Price to Sales (P/S)0.00
P/FCF Ratio-67.25
Enterprise Value/Market Cap1.39
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-27.92
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Stimcell Energetics News
STME FAQ
What was Stimcell Energetics’s price range in the past 12 months?
Stimcell Energetics lowest stock price was $0.25 and its highest was $0.48 in the past 12 months.
What is Stimcell Energetics’s market cap?
Stimcell Energetics’s market cap is $5.83M.
When is Stimcell Energetics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Stimcell Energetics’s earnings last quarter?
Currently, no data Available
Is Stimcell Energetics overvalued?
According to Wall Street analysts Stimcell Energetics’s price is currently Overvalued.
Does Stimcell Energetics pay dividends?
Stimcell Energetics does not currently pay dividends.
What is Stimcell Energetics’s EPS estimate?
Stimcell Energetics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Stimcell Energetics have?
Stimcell Energetics has 21,141,272 shares outstanding.
What happened to Stimcell Energetics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Stimcell Energetics?
Currently, no hedge funds are holding shares in STME
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Stimcell Energetics
StimCell Energetics Inc. is a biotechnology company focused on the research, development, and market introduction of both therapeutic and non-therapeutic solutions. These products are intended to benefit individuals in the United States who are managing conditions such as diabetes, Parkinson's disease, hypertension, neuropathy, and issues with kidney function. The company's primary product line is the eBalance system, which comprises two versions: the eBalance Pro System, designed for clinical application by healthcare practitioners, and the eBalance Home System, created for personal use to promote overall well-being and alleviate pain. Both systems are operated via the eBalance Console, a central control unit that offers three distinct pre-programmed microcurrent algorithms: one for general wellness, another for pain relief, and a 'dual' mode that combines both. Additionally, these eBalance products aim to provide temporary relief for discomfort in various body parts, including the shoulders, waist, back, neck, arms, and legs. Established in 2010, the company initially operated under the name Cell MedX Corp. before officially rebranding as StimCell Energetics Inc. in November 2024. Its corporate headquarters are located in Vancouver, Canada.
Technical Analysis
Ownership Overview
19.70%
Insiders
― Other Institutional Investors
80.30% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---